Summary: Sorin Gets CE Mark Approval For Heart Valve
InfoGrok Healthcare, a leading healthcare industry news and industry suppliers company is reporting that the medical device company Sorin Group has received a CE Mark approval for the commercial availability of the self- anchoring Perceval S aortic heart valve in Europe. According to the company, the Perceval S Sutureless biological valve is indicated for the [...]
InfoGrok Healthcare, a leading healthcare industry news and
industry suppliers company is reporting that the medical device
company Sorin Group has received a CE Mark approval for the
commercial availability of the self- anchoring Perceval S aortic
heart valve in Europe. According to the company, the Perceval S
Sutureless biological valve is indicated for the [...]
Date Published: Feb 08, 2011 - 9:45 pm
Researchers have further established that longterm use of statins
is unlikely to substantially increase or decrease overall cancer
risk, according to a new study.
Date Published:
Young people with even modestly elevated cholesterol levels are
more likely to develop coronary artery calcium and atherosclerosis
later in life, according to a 20year study.
Date Published:
In the largest and most reliable study of its type, researchers in
the UK and Australia have demonstrated that statin therapy is not a
cause of increased cancer rates and deaths.
Date Published:
Cholesterol influences the health of our hearts and blood vessels.
Conventional treatment attempts to reduce the level of bad
cholesterol, LDL cholesterol, in the blood plasma. The opposite
approach, which involves increasing the concentration of good HDL
cholesterol using nicotinic acid, has proven unpopular among
patients up to now.
Date Published: